We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking BBOT? Get live short interest, options flow, and signals on ORTEX.Sign up free →
BB

BridgeBio Oncology Therapeutics, Inc. (BBOT) short interest & options flow

NASDAQ

BridgeBio Oncology Therapeutics heads into the back half of 2026 with a fresh Street endorsement pulling against a persistently elevated short score — the tension between analyst conviction and bearish positioning is the defining feature of the stock right now. The most concrete development this week is JP Morgan's initiation of coverage with an Overweight rating and a $27 price…

$2.30+12.75% 1d-0.43% 1w-30.51% 1mClose: 9 Nov 2026
Availability
Rising
Live availability on ORTEX →
Market cap
$184M
Next earnings
11 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 10 Nov 2026

ORTEX chart of BridgeBio Oncology Therapeutics, Inc. (BBOT) share price and short interest (% of free float), six months to November 9, 2026

BBOT news and analysis

RSS

No long-form analysis yet for BBOT. Pulse alerts and the live data picture are available on ORTEX.

Open BBOT on ORTEX →

Want the live picture for BBOT?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BBOT — free to start on ORTEX.

Sign up for free →Open BBOT on ORTEX